^125I放射性粒子组织间植入在局部进展期胰腺癌治疗中的研究进展  

Progress in Radioactive ^125I Seeds Interstitial Implantation in the Treatment for Locally Advanced Pancreatic Cancer

作　　者：俞炎平[1] 

机构地区：[1]浙江省肿瘤医院,浙江杭州310022

出　　处：《中国肿瘤》2013年第5期384-387,共4页China Cancer

基　　金：浙江省医药卫生科研基金(2009B021)

摘　　要：胰腺癌是难治恶性肿瘤之一,其发病率及死亡率均较高,缺乏有效治疗手段,近年来我国相继开展125I放射性粒子植入治疗局部进展期胰腺癌。放射性粒子植入治疗肿瘤具有微创、并发症少、安全性高等特点,并可提高肿瘤局部控制率和患者生存质量。全文就125I放射性粒子植入治疗胰腺癌的治疗方法、安全性及临床疗效作一综述。Pancreatic cancer serves as one malignant cancer with complicated treatment. The lack of effective therapy ascribes to the high incidence and mortality rate. In recent years,radioactive 125I seeds implantation in the treatment for locally advanced pancreatic cancer have emerged in China. This therapy skill possesses the characteristics of minimal invasion,less complication and good safety,and it can also improve the local control rate and the quality of life of patient. This review summarizes the treatment methods,safety and clinical efficacy of radioactive 125I seeds implantation in the treatment for locally advanced pancreatic cancer.

关 键 词：胰腺癌 125I粒子 组织间植入 

分 类 号：R735.9[医药卫生—肿瘤]